RFM
AMPE

Royal Fund Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Royal Fund Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-13
Closed -$1K – 619
2020
Q1 		$1K Hold
13
– – ﹤0.01% 551
2019
Q4 		$2K Hold
13
– – ﹤0.01% 558
2019
Q3 		$2K Hold
13
– – ﹤0.01% 538
2019
Q2 		$1K Hold
13
– – ﹤0.01% 525
2019
Q1 		$2K Hold
13
– – ﹤0.01% 524
2018
Q4 		$1K Buy
+13
New +$2K ﹤0.01% 562

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return

Royal Fund Management's AMPE Position: Q2 2020 in Review

Royal Fund Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2020, closing a stake of 13 shares — an estimated $1K sold.

Royal Fund Management first reported a position in AMPE in Q4 2018 and held it in 6 quarters. The position peaked at $2K in Q4 2019. 79 funds tracked by Wall St. Rank hold AMPE as of Q2 2020.

  • Royal Fund Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2020 after selling out during the quarter.
  • Royal Fund Management sold 13 Ampio Pharmaceuticals Inc. shares in Q2 2020, an estimated $1K.
  • Royal Fund Management first reported a position in Ampio Pharmaceuticals Inc. in Q4 2018 and held it in 6 quarters.
  • Royal Fund Management's Ampio Pharmaceuticals Inc. position peaked at $2K in Q4 2019.
  • 79 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2020.

Based on Royal Fund Management's 13F filing for Q2 2020, filed 6 Aug 2020.